Jun 3 |
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
|
May 30 |
Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
|
May 30 |
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
|
May 30 |
Q1 2024 Burning Rock Biotech Ltd Earnings Call
|
May 29 |
Burning Rock Biotech Limited (BNR) Q1 2024 Earnings Call Transcript
|
May 29 |
Burning Rock Biotech Limited 2024 Q1 - Results - Earnings Call Presentation
|
May 29 |
Burning Rock Biotech GAAP EPS of -$0.16, revenue of $17.4M
|
May 29 |
Burning Rock Reports First Quarter 2024 Financial Results
|
May 23 |
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
|
May 14 |
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
|